导航

| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 30.05% | 149/4773 |
| 近一周 | 2.17% | 170/5465 |
| 近一月 | -6.42% | 4175/5421 |
| 近一季 | -11.29% | 3906/5231 |
| 近半年 | 22.76% | 156/4920 |
| 近一年 | 33.95% | 179/4394 |
| 近两年 | 194.70% | 96/2954 |
| 近三年 | 132.27% | 54/2253 |
| 成立以来 | 72.78% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.25% 4079/4961 |
107.51% 60/5312 |
- - |
- - |
| 2025 | 40.73% 762/4813 |
0.57% 1814/3635 |
-0.39% 2915/4076 |
53.31% 251/4524 |
-8.37% 3907/4813 |
| 2024 | 31.36% 98/3463 |
-9.42% 2284/2808 |
0.57% 578/3014 |
18.70% 956/3129 |
21.48% 29/3463 |
| 2023 | -6.73% 872/2656 |
14.49% 240/2280 |
-8.45% 1997/2385 |
-9.76% 1892/2515 |
-1.38% 317/2655 |
| 2022 | -38.36% 1761/2207 |
-21.66% 1645/1919 |
0.61% 1538/2016 |
-21.29% 1900/2113 |
-0.63% 1633/2208 |
| 2021 | 38.77% 40/1822 |
-7.35% 1062/1255 |
42.32% 14/1330 |
-1.56% 531/1466 |
6.91% 199/1822 |
| 2020 | - - |
- - |
- - |
-2.48% 1074/1164 |
7.03% 731/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 港股医疗ETF | 1.4546 | 31.90% |
| 华富中证港股通创新药指数型发起式A | 1.1637 | 30.96% |
| 天弘恒生沪深港创新药精选50ETF发起联接A | 1.3128 | 30.52% |
| 中欧中证港股通创新药指数发起A | 1.6103 | 30.52% |
| 嘉实中证港股通创新药指数发起式C | 0.8566 | 30.50% |
| 中欧中证港股通创新药指数发起C | 1.4583 | 30.44% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8927 | 30.26% |
| 景顺长城中证港股通创新药ETF联接C | 1.4696 | 29.97% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8736 | 29.94% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8719 | 29.88% |
| 鹏华国证半导体芯片ETF VS. 长安沪深300非周期A(740101) |